Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
51.3M
-
Shares change
-
-350K
-
Total reported value, excl. options
-
$148M
-
Value change
-
-$3.07M
-
Put/Call ratio
-
0.28
-
Number of buys
-
46
-
Number of sells
-
-62
-
Price
-
$2.88
Significant Holders of Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) as of Q1 2025
144 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2025.
Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.3M shares
of 54M outstanding shares and own 94.94% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.2M shares), TCG Crossover Management, LLC (5.25M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.07M shares), Nantahala Capital Management, LLC (4.82M shares), BlackRock, Inc. (4.71M shares), VANGUARD GROUP INC (3.22M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3M shares), DIMENSIONAL FUND ADVISORS LP (1.41M shares), STATE STREET CORP (1.25M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.23M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.